Genomic News and Research

RSS
Scientists develop high-throughput strategy to build de novo genomes

Scientists develop high-throughput strategy to build de novo genomes

Veracyte named to Bay Area News Group's Top Workplaces list for second consecutive year

Veracyte named to Bay Area News Group's Top Workplaces list for second consecutive year

Scientists examine rates of secondary mutations in biomarker genes

Scientists examine rates of secondary mutations in biomarker genes

Six Catalonia research centres collaborate to set up The Barcelona Institute of Science and Technology

Six Catalonia research centres collaborate to set up The Barcelona Institute of Science and Technology

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

SeraCare Life Sciences inks CRADA with NCI to create positive controls for cancer assays

New Internet tool may help analyze genes based on their evolutionary profile

New Internet tool may help analyze genes based on their evolutionary profile

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

E2F4 biomarker can help predict prognosis and response to BCG therapy in bladder cancer

Study: Acellular vaccines may have contributed to recent pertussis outbreak

Study: Acellular vaccines may have contributed to recent pertussis outbreak

Medical students show greater acceptance of using approaches in genomic medicine than practicing physicians

Medical students show greater acceptance of using approaches in genomic medicine than practicing physicians

Broad Institute teams up with Google to increase access to research tools

Broad Institute teams up with Google to increase access to research tools

Johns Hopkins researchers identify multiple genetic changes that may increase risk of pancreatic cancer

Johns Hopkins researchers identify multiple genetic changes that may increase risk of pancreatic cancer

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Advanced Cell Diagnostics raises $22 million in Series C equity financing

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

UNC Lineberger scientists contribute to better understanding of genetic mutations in melanoma

UNC Lineberger scientists contribute to better understanding of genetic mutations in melanoma

Scientists identify four melanoma subtypes that share common 'downstream' signaling pathways

Scientists identify four melanoma subtypes that share common 'downstream' signaling pathways

Mayo Clinic, TGen researchers help launch national clinical trial to treat advanced skin cancer patients

Mayo Clinic, TGen researchers help launch national clinical trial to treat advanced skin cancer patients

International researchers identify previously unknown genetic immunodeficiency

International researchers identify previously unknown genetic immunodeficiency

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Researchers find new way to potentially stop progression of late-stage cancers

Researchers find new way to potentially stop progression of late-stage cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.